I partner with clients to secure their innovations and provide IP strategies that further their key business objectives.
Hathaway practices intellectual property law with a focus on the life sciences industry. She has extensive experience assisting pharmaceutical companies, start-up biotechnology companies, established biopharmaceutical corporations, and academic institutions with competitive landscape analyses, freedom-to-operate assessments, due diligence evaluations of patent portfolios, patent opinions, and investigation and resolution of inventorship disputes.
She architects and implements global patent strategies for high-value therapeutics, securing comprehensive patent portfolios that protect HUMIRA®, IMBRUVICA®, SKYRIZI®, VENCLEXTA®, QULIPTA®, UBRELVY®, VIBERZI®, VYALEV®, and other therapeutics. As Managing Partner, Hathaway is responsible for the firm’s day-to-day operations, while furthering its strategic goals for client service, diversity, culture, and overall growth.
Bowdoin College, B.A., Neuroscience, magna cum laude
Bar and Court Admissions
BAR ADMISSIONS
Massachusetts
Texas
U.S. Patent & Trademark Office (Agency)
Languages
Spanish
Experience
Management of blockbuster drug portfolio
Management of personalized medicine patent portfolios
Active engagement with the U.S. Patent and Trademark Office interviewing patent cases
Advised on patent strategy and policy issues for venture-backed Coalition of advanced diagnostics companies
Amicus briefs to Supreme Court in Mayo Collaborative and Mayo Clinic Rochester v. Prometheus Laboratories and Association for Molecular Pathology v. Myriad Genetics, Inc. cases
Speaks regularly at U.S. Patent and Trademark Office
Provided non-infringement patent opinions in electrochemical industry
Other Publications
AIPLA comments on behalf of the Biotechnology Committee on proposed rules of practice pertaining to "Revision to the Time for Filing of a Biological Deposit and the Date of Availability of a Biological Deposit" (April 2008)
Assisted in drafting accepted application entitled "A Case Study of a Biotechnology-Related Action Before the International Trade Commission" for BIO (2008)
AIPLA comments on behalf of the Biotechnology Committee on the proposed rules of practice pertaining to claims using alternative language (October 2007)
Honors & Involvement
HONORS
Best Lawyers: Patent Law (2027)
Best Lawyers: Litigation - Intellectual Property (2025-2026), Patent Law (2026)
Massachusetts Lawyers Weekly
Go To Lawyer for Life Sciences/Healthcare (2024)
Top Women of Law (2023)
Massachusetts Super Lawyers: "Rising Star" in Intellectual Property (2011-2014)
LSPN Patent Prosecutor of the Year Award, Highly Commended (2025)
WIPR Influential Women in IP (2025-2026)
INVOLVEMENT
Boston Bar Association (BBA), Co-Chair, Law Leadership Forum
American Intellectual Property Law Association (AIPLA)
Chair Women in IP Committee, October 2013-2017
Vice-Chair Women in IP Committee, October 2011-2013
Vice-Chair Education Committee, October 2009-October 2011
Chair Women's National Networking Event, October 2009-October 2015
Chair of Subcommittee of Legislative Policy for Biotechnology Committee
Pro Bono matters for Boston Housing Authority
Participates as a coach for VC 101 for Center for Women & Enterprise
Boston Intellectual Property Law Association (BIPLA), Member
American Bar Association, Member
Other Events
“Managing Your IP Portfolio: The In-House Perspective,” Rocky Mountain Intellectual Property & Technology Law Conference (June 2022)
“Recent Developments in Patent Subject Matter Eligibility under 35 U.S.C. 101,” North Carolina Bar Association IP Section’s Annual CLE Symposium (March 2015)
“Recent Supreme Court Case Law & Implications for Medical Device and Diagnostic Industries,” Medical Device and Diagnostics IP/Patent Strategy Conference (March 2015)
"The Impact of the America Invents Act on Innovations," The Forsyth Institute (April 2013)
Public Hearing on Genetic Testing, USPTO (January 2013)
"Personalized Medicine: Intellectual Property Protection, FDA Regulation and Reimbursement," AUTM 2012 (March 2012)
"Diagnostics - The Changing IP and Regulator Landscape," G2 Intelligence’s Molecular Diagnostics Conference (April 2011)
"Genetics in the Regulatory & Policy Realm," 3rd Annual Consumer Genetics Conference (June 2011)
"Using the Internet For Litigation and Prosecution in the New Information Age” (February 2011)
“Teaching Children About Patent Law and Innovation” (February 2011)
“Understanding the Implications of the Rapidly Evolving U.S. Healthcare and Regulatory Environment," AusBiotech 2010 (October 2010)
"Maintaining and Gaining Career, Momentum in Spite of the Economic Downturn," American Intellectual Property Law Association (January 2010)
Co-Organizer, Consumer Genetics Conference (June 2010 and June 2009)
"Overview of the Requirements for Patentability," AIPLA Boot Camp: 2008 Practical Patent Prosecution Training for New Lawyers (August 2009 and August 2008)
“Making Sense of the Data and Explaining It to the Consumer," Consumer Genetics Conference (June 2009)
"Genetics and the Law: Intellectual Property, Regulation and Public Policy," Consumer Genetics Conference (June 2009)
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
